Covaxin COVID-19 Vaccine Found To Be Safe and Immunogenic in 2-18 Years Old Volunteers in Phase II/III Trials, Says Bharat Biotech
Recently Covaxin has been approved for emergency use on children between the age of 12 and 18 by the Drugs Controller General of India (DCGI).
Bharat Biotech has said that its COVID-19 vaccine, Covaxin has proven to be safe, well-tolerated, and immunogenic in 2-18 years old volunteers in phase II/III trials.
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)